Hims vs LifeMD
LifeMD costs $50 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →
LifeMD
Best for: bloodwork inside the monthly price rather than billed on top
Visit LifeMD →If you are choosing between Hims and LifeMD, the first difference is cost: LifeMD is $50 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. LifeMD leads our six-part score, 7.9 to 6.8. One of the two has an FDA warning letter on record, covered below.
Hims vs LifeMD price
LifeMD is the cheaper way in: $149 a month against $199 a month at Hims. That is $50 less each month (25% lower), or about $600 over a year of treatment.
Drug by drug: Semaglutide is cheaper at LifeMD ($149 a month vs $199 a month); tirzepatide is cheaper at Hims ($299 a month vs $349 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Hims prices compounded injections and brand-name pens, while LifeMD prices brand-name pens.
Where each one treats patients
Hims lists 50 states, and LifeMD lists 50 states.
They overlap in 50 states.
Pricing
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
LifeMD
First month $75, then $149/mo. Brand medication billed separately, or $0-$25/mo copay with commercial insurance.
Medication only; plus the $149/mo program fee.
Medication only (starting); plus the program fee. As low as $0-$25/mo with insurance.
Medication only; plus the $149/mo program fee.
What each price covers
Hims' price also covers the medication itself, which LifeMD does not claim.
LifeMD's price also covers the clinician visit, lab work and coaching, which Hims does not claim.
Hims is silent on shipping and lab work.
LifeMD is silent on shipping.
That matters most for the drug: unless LifeMD confirms otherwise, budget for medication on top of its listed price.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
LifeMD
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, LifeMD scores 7.9 and Hims 6.8 out of 10.
Hims is stronger on user experience (8.0 vs 3.0) and trust & safety (7.0 vs 6.0).
LifeMD is stronger on value (10.0 vs 3.0) and support (5.5 vs 3.0).
Effectiveness and accessibility are within half a point.
Hims
6.8/10
LifeMD
7.9/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
LifeMD has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hims | LifeMD |
|---|---|---|
| Starting Price | $199/mo | ✓$149/mo |
| Features | ✓2 features | 0 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →About LifeMD
LifeMD is a publicly traded telehealth seller. It carries brand-name GLP-1 medications only.
Read our full LifeMD review →Pros & Cons
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
LifeMD
What we like
- Semaglutide costs $149 a month, 85% below the $990 median for brand-name semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- The monthly price includes clinician visits, lab work and coaching
- Serves all 50 states
- We found no FDA warning letters issued to LifeMD
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Not included in the monthly price: medication
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
LifeMD wins this one, 7.9 to 6.8, above all for bloodwork inside the monthly price rather than billed on top. It also costs $50 less each month than Hims. Hims fits better if knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC is your priority.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Choose LifeMD if…
You want bloodwork inside the monthly price rather than billed on top and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Hims vs LifeMD: FAQ
Close alternatives to Hims and LifeMD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.